Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL78369 | 0.91 | — | — | |
| SCHEMBL5648243 | 0.81 | NOS2 (0.33) | NOS2 | |
| SCHEMBL15328487 | 0.77 | — | — | |
| SCHEMBL1146008 | 0.77 | — | — | |
| SCHEMBL1146005 | 0.77 | — | — | |
| SCHEMBL14142064 | 0.76 | — | — | |
| SCHEMBL2115184 | 0.73 | — | — | |
| SCHEMBL1845097 | 0.73 | — | — | |
| SCHEMBL23053041 | 0.71 | — | — | |
| SCHEMBL10823486 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 787 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3578541-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY, AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-05-28 | — | — | EP | claimed |
| US-20240116854-A1 | CYCLOPROPYLAMIDE COMPOUNDS AGAINST PARASITES IN FISH | INTERVET INC. (US) | 2024-04-11 | — | — | US | claimed |
| CN-117241669-A | Cyclopropylamide compounds against parasites in fish | 英特威国际有限公司荷兰疫苗厂 | 2023-12-15 | — | — | CN | claimed |
| EP-4284174-A1 | CYCLOPROPYLAMIDE COMPOUNDS AGAINST PARASITES IN FISH | Intervet International B.V. (NL) | 2023-12-06 | — | — | EP | claimed |
| US-20230049294-A1 | STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES | Atea Pharmaceuticals, Inc. (US) | 2023-02-16 | — | — | US | claimed |
| WO-2022162001-A1 | CYCLOPROPYLAMIDE COMPOUNDS AGAINST PARASITES IN FISH | INTERVET INTERNATIONAL B.V. (NL) | 2022-08-04 | — | — | WO | claimed |
| WO-2021216722-A1 | STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES | Atea Pharmaceuticals, Inc. (US) | 2021-10-28 | — | — | WO | claimed |
| CN-107529748-B | Molecules having pesticidal utility, and intermediates, compositions and methods related thereto | 美国陶氏益农公司 | 2020-12-25 | — | — | CN | claimed |
| EP-3578541-A1 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITION, AND PROCESSES, RELATED THERETO | Dow AgroSciences LLC (US) | 2019-12-11 | — | — | EP | claimed |
| EP-3283460-B1 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITION, AND PROCESSES, RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2019-05-22 | — | — | EP | claimed |
| US-20040138439-A1 | inhibitors of sodium dependent glucose transporters found in the intestine and kidney (SGLT2), and more particularly to a process of producing such compounds, for example 1-C-(substituted diphenylmethane-3-yl)- beta -D-glucopyranose | ASTRAZENECA AB (SE) | 2004-07-15 | — | — | US | claimed |
| EP-0850262-B1 | SELECTIVELY FUNCTIONALIZABLE DESDENDRIMERS | BRACCO SPA (IT) | 2001-05-23 | — | — | EP | claimed |
| US-5994495-A | Selectively functionalizable desdendrimers | DIBRA S.P.A. (IT) | 1999-11-30 | — | — | US | claimed |
| US-5807971-A | CORE WITH POLYOXAALKYLENE BRANCHES | DIBRA S.P.A. (IT) | 1998-09-15 | — | — | US | claimed |
| EP-0850262-A1 | SELECTIVELY FUNCTIONALIZABLE DESDENDRIMERS | BRACCO S.p.A. (IT) | 1998-07-01 | — | — | EP | claimed |
| WO-1997010281-A1 | SELECTIVELY FUNCTIONALIZABLE DESDENDRIMERS | BRACCO S.P.A. (IT) | 1997-03-20 | — | — | WO | claimed |
| EP-0641346-B1 | 7'-AMINO-NAPHTHAZARIN ANTIBIOTIC DERIVATIVES | LEPETIT SPA (IT) | 1996-05-29 | — | — | EP | claimed |
| US-5475010-A | Vaginal infections | GRUPPO LEPETIT S.P.A. (IT) | 1995-12-12 | — | — | US | claimed |
| EP-0641346-A1 | 7'-AMINO-NAPHTHAZARIN ANTIBIOTIC DERIVATIVES. | LEPETIT SPA (IT) | 1995-03-08 | — | — | EP | claimed |
| WO-1993012115-A1 | 7'-AMINO-NAPHTHAZARIN ANTIBIOTIC DERIVATIVES | GRUPPO LEPETIT S.P.A. (IT) | 1993-06-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116854-A1 | CYCLOPROPYLAMIDE COMPOUNDS AGAINST PARASITES IN FISH | PIGO, PPIA, PPT1 | NOS2 358/4885 |
| US-20230049294-A1 | STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES | NUDT1, PNP, ITPA | NOS2 4098/4885 |
| US-20040138439-A1 | inhibitors of sodium dependent glucose transporters found in the intestine and kidney (SGLT2), and more particularly to a process of producing such compounds, for example 1-C-(substituted diphenylmethane-3-yl)- beta -D-glucopyranose | SLC5A1, SLC5A2, SLC2A1 | NOS2 3108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.